World's Best Scientists 2026 revealed!
Hans-Georg Rammensee

Hans-Georg Rammensee

D-Index & Metrics

Immunology

D-Index
126
Citations
68628
World Ranking
266
National Ranking
13

Medicine

D-Index
127
Citations
69025
World Ranking
2807
National Ranking
145

Research.com Recognitions

  • 1996 - Paul Ehrlich and Ludwig Darmstaedter Prize
  • 1993 - Robert Koch Prize

Overview

Hans-Georg Rammensee is affiliated with the University of Tübingen in Germany. Their research spans multiple fields, primarily focusing on Medicine and Biochemistry, Genetics and Molecular Biology. Within these fields, their work extensively covers subfields such as Infectious Diseases, Molecular Biology, and Pathology and Forensic Medicine.

Their research topics include SARS-CoV-2 and COVID-19 studies, COVID-19 clinical research, vaccines and immunoinformatics approaches, SARS-CoV-2 detection and testing, chromatin remodeling and cancer, protein degradation and inhibitors, as well as cancer mechanisms and therapy.

Several frequent co-authors have collaborated with them, including:

  • Juliane S. Walz
  • Annika Nelde
  • Jonas S. Heitmann
  • Andreas Peter
  • Sebastian Hörber

Their publications appear regularly in venues such as:

  • Nature Immunology
  • Nature Communications
  • Journal for ImmunoTherapy of Cancer
  • Immunogenetics

Notable recent papers include:

  • "SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition" (2020, Nature Immunology)
  • "Exploring beyond clinical routine SARS-CoV-2 serology using MultiCoV-Ab to evaluate endemic coronavirus cross-reactivity" (2021, Nature Communications)
  • "Natural and cryptic peptides dominate the immunopeptidome of atypical teratoid rhabdoid tumors" (2021, Journal for ImmunoTherapy of Cancer)
  • "Kirsten Falk 1963-2024" (2025, Immunogenetics)

Throughout their career, Hans-Georg Rammensee has received awards including the Paul Ehrlich and Ludwig Darmstaedter Prize in 1996 and the Robert Koch Prize in 1993.

Best Publications

  • Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules.

    K Falk;O Rötzschke;S Stevanović;G Jung

  • SYFPEITHI: database for MHC ligands and peptide motifs.

    H. G. Rammensee;J. Bachmann;N. P. N. Emmerich;O. A. Bachor

  • Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens

    Matthew M. Gubin;Xiuli Zhang;Heiko Schuster;Etienne Caron

  • MHC ligands and peptide motifs: first listing.

    Hans-Georg Rammensee;Thomas Friede;Stefan Stevanović

  • Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival

    Steffen Walter;Toni Weinschenk;Arnulf Stenzl;Romuald Zdrojowy

  • Peptides Naturally Presented by MHC Class I Molecules

    Hans-Georg Rammensee;Kirsten Falk;Olaf Rotzschke

  • Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells.

    Olaf Rötzschke;Kirsten Falk;Karl Deres;Hansjörg Schild

  • Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy.

    Hermann Einsele;Eddy Roosnek;Nathalie Rufer;Christian Sinzger

  • Actively personalized vaccination trial for newly diagnosed glioblastoma

    Norbert Hilf;Sabrina Kuttruff-Coqui;Katrin Frenzel;Valesca Bukur

  • In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine

    Karl Deres;Hansjörg Schild;Karl-Heinz Wiesmüller;Günther Jung

  • Characterization of a murine monoclonal antibody specific for an allotypic determinant on T cell antigen receptor.

    U D Staerz;H G Rammensee;J D Benedetto;M J Bevan

  • Cutting Edge: Down-Regulation of MICA on Human Tumors by Proteolytic Shedding

    Helmut R. Salih;Hans-Georg Rammensee;Alexander Steinle

  • Autophagy promotes MHC class II presentation of peptides from intracellular source proteins

    Jörn Dengjel;Oliver Schoor;Rainer Fischer;Michael Reich

  • Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia

    Helmut Rainer Salih;Holger Antropius;Friederike Gieseke;Stefan Zoltan Lutz

  • In vivo application of RNA leads to induction of specific cytotoxic T lymphocytes and antibodies.

    Ingmar Hoerr;Reinhard Obst;Hans-Georg Rammensee;Günther Jung

  • The Tübingen approach: identification, selection, and validation of tumor-associated HLA peptides for cancer therapy

    Harpreet Singh-Jasuja;Niels P. N. Emmerich;Hans-Georg Rammensee

  • The endoplasmic reticulum-resident heat shock protein Gp96 activates dendritic cells via the Toll-like receptor 2/4 pathway.

    Ramunas M Vabulas;Sibylla Braedel;Norbert Hilf;Harpreet Singh-Jasuja

  • Clonal anergy induced in mature Vβ6 + T lymphocytes on immunizing Mls-1 b mice with Mls-1 a expressing cells

    Hans-Georg Rammensee;Ruth Kroschewski;Bernard Frangoulis

  • SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition.

    Annika Nelde;Tatjana Bilich;Jonas S. Heitmann;Yacine Maringer

  • Unexpected Abundance of HLA Class II Presented Peptides in Primary Renal Cell Carcinomas

    Jörn Dengjel;Maria-Dorothea Nastke;Cécile Gouttefangeas;Gitsios Gitsioudis

  • Identification of HLA-A2–Restricted T-Cell Epitopes Derived From the MUC1 Tumor Antigen for Broadly Applicable Vaccine Therapies

    Peter Brossart;Kathrin S. Heinrich;Gernot Stuhler;Lars Behnke

Frequent Co-Authors

Stefan Stevanovic
Stefan Stevanovic University of Tübingen
Lothar Kanz
Lothar Kanz University of Tübingen
Hansjörg Schild
Hansjörg Schild Johannes Gutenberg University of Mainz
Arnulf Stenzl
Arnulf Stenzl University of Tübingen
Peter Brossart
Peter Brossart University Hospital Bonn
Rupert Handgretinger
Rupert Handgretinger University of Tübingen
Oliver Kohlbacher
Oliver Kohlbacher University of Tübingen
Pierre-Yves Dietrich
Pierre-Yves Dietrich University of Geneva
Christian Münz
Christian Münz University of Zurich
Günther Jung
Günther Jung University of Tübingen

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Immunology, pursuing related healthcare degrees can open diverse career opportunities. Many opt for accelerated nursing pathways, such as programs considered the easiest absn program to get into. These programs allow individuals with a non-nursing background to fast-track their Bachelor of Science in Nursing (BSN) credentials.

Entry-level options like Licensed Practical Nurse (LPN) programs also play a crucial role in building clinical experience. Programs with lpn programs with easiest admission requirements offer accessible pathways to healthcare careers while still providing foundational knowledge beneficial to immunology-related roles.

For advanced practice, learners often explore nurse practitioner degrees. Identifying the what is the easiest np program can help in selecting a program that balances admission criteria with comprehensive training in patient care.

Specializing further, psychiatric mental health nurse practitioner roles are in demand. Many students choose programs recognized as the best online pmhnp programs due to their strong clinical placement rates, which enhance hands-on experience crucial for career advancement.

Best Scientists Citing Hans-Georg Rammensee

Trending Scientists

Recently Published Articles